Michael Barbella, Managing Editor12.02.23
MPO website visitors kicked off the 2023 holiday season in a heartwarming manner this past week, fancying an exclusive interview with Abbott Laboratories Chief Medical Officer Philip B. Adamson, M.D., on the latest advancements in heart failure treatment. Adamson discussed the company's CardioMEMS HF System and the importance of medical education and training to improve patient outcomes.
Runner-up to the online exclusive was MGS's rebrand. Focused solely on the healthcare industry, the new brand elevates MGS’ status as a single-source solutions provider to pharmaceutical, diagnostic and medtech companies worldwide. The brand revamp follows strategic acquisitions of European toolmaker Formteknik, Danish product development and design firm Technolution, and Winther Mould Technology, a Danish healthcare tooling manufacturer.
Royal Philips' mobile MRI system with helium-free operations drove significant traffic as well. On display at RSNA23, Philips' BlueSeal MR Mobile is a 1.5T fully sealed magnet that delivers patient-centric MRI services at the time and place needed. Unlike other mobile MRI scanners, the BlueSeal MR Mobile is more agile and lightweight so it can be located in more convenient places for patients, such as near a hospital’s main entrance.
Paragonix Technologies and AWAK Technologies amassed significant pageviews as well. Paragonix enticed cybervisitors to the MPO website with news that it launched a comprehensive network of donor organ procurement, preservation, and transportation services. The expansion will establish seven U.S. procurement hubs in an effort to optimize coordination and logistics for the transplant community.
AWAK, meanwhile, gained favor with MPO loyalists for gaining FDA breakthrough status for its kidney disease progression prediction (KDPP) artificial intelligence model for chronic kidney disease patient care. The KDPP model, according to AWAK, helps evaluate the risk of kidney disease progression and initiation of renal replacement therapy within one, two, and five years.
Runner-up to the online exclusive was MGS's rebrand. Focused solely on the healthcare industry, the new brand elevates MGS’ status as a single-source solutions provider to pharmaceutical, diagnostic and medtech companies worldwide. The brand revamp follows strategic acquisitions of European toolmaker Formteknik, Danish product development and design firm Technolution, and Winther Mould Technology, a Danish healthcare tooling manufacturer.
Royal Philips' mobile MRI system with helium-free operations drove significant traffic as well. On display at RSNA23, Philips' BlueSeal MR Mobile is a 1.5T fully sealed magnet that delivers patient-centric MRI services at the time and place needed. Unlike other mobile MRI scanners, the BlueSeal MR Mobile is more agile and lightweight so it can be located in more convenient places for patients, such as near a hospital’s main entrance.
Paragonix Technologies and AWAK Technologies amassed significant pageviews as well. Paragonix enticed cybervisitors to the MPO website with news that it launched a comprehensive network of donor organ procurement, preservation, and transportation services. The expansion will establish seven U.S. procurement hubs in an effort to optimize coordination and logistics for the transplant community.
AWAK, meanwhile, gained favor with MPO loyalists for gaining FDA breakthrough status for its kidney disease progression prediction (KDPP) artificial intelligence model for chronic kidney disease patient care. The KDPP model, according to AWAK, helps evaluate the risk of kidney disease progression and initiation of renal replacement therapy within one, two, and five years.